August 26, 2021
Injecting a syringe of an unapproved treatment into a patient’s eyeball would be a nightmare scenario for most ophthalmologists. But that is what many major insurance companies are now suggesting doctors do.
August 11, 2021
Health care in the United States has quietly turned a big corner. Just as the FDA approved its first interchangeable biosimilar, Oklahoma became the 50th and final state where pharmacists can substitute these lower-cost versions of biologic drugs.
July 13, 2021
I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.
July 9, 2021
The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”
June 24, 2021
Biosimilars are increasing the number of safe, effective treatments for cancer.
June 24, 2021
Biosimilars offer more cancer treatment options at potentially lower prices. So why aren’t they more accessible?
May 19, 2021
For 20 years there wasn’t a single medication I could prescribe to help my patients overcome multiple sclerosis, a disease that gradually robbed them of their strength, vision, coordination, and also memory and thinking abilities.
April 13, 2021
Everyone, it seemed, was willing to help patients access medication without delay when COVID-19 took hold last year.
January 19, 2021
A new federal experiment could force tens of thousands of patients off of their medication in 2021.
December 18, 2020
The fifth annual National Policy & Advocacy Summit on Biologics brought together health care providers, policy experts, patient advocates and…